BioCentury
ARTICLE | Company News

Biocortech SAS, Columbia University deal

February 27, 2006 8:00 AM UTC

Biocortech and the university partnered to study how differential mRNA editing of the serotonin (5-HT2C) receptor affects depression. The deal combines Biocortech's technology for generating editing ...